Xenon Pharmaceuticals Inc.
METHODS AND USES FOR TREATING ANHEDONIA
Last updated:
Abstract:
The present disclosure is directed to, among other things, methods and uses for treating anhedonia in a subject, such as a human, wherein the methods comprise administering a therapeutically effective amount of N-[4-(6-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)-2,6-dimethylphenyl]-3,3-d- imethylbutanamide (Compound A) to the subject in need thereof, and the uses comprise Compound A for use in treating anhedonia in a subject, such as a human. The present disclosure is further directed to various improved methods of therapy and administration of Compound A.
Status:
Application
Type:
Utility
Filling date:
9 Feb 2022
Issue date:
25 Aug 2022